治療におけるバーチャルリアリティ市場- 世界の産業規模、シェア、動向、機会、予測、セグメント別、技術別、デバイス別、用途別、地域別、競合、2019年～2029年

世界の治療におけるバーチャルリアリティ市場は2023年に23億1,000万米ドルと評価され、予測期間中のCAGRは13.24%で2029年には49億1,000万米ドルに達すると予測されています。

治療におけるバーチャルリアリティ（VR）市場とは、様々な心理的・身体的状態を治療するために、没入型バーチャルリアリティ技術を治療行為に統合することを指します。この革新的なアプローチは、患者が恐怖に立ち向かったり、社会的スキルを練習したり、リハビリを目的としたシナリオを体験したりするのに役立つ制御された環境を作り出すために、VRシミュレーションを利用します。VR療法には、不安障害、恐怖症、心的外傷後ストレス障害（PTSD）に対する暴露療法など、幅広い用途があり、患者は安全で管理された環境で徐々に恐怖と向き合うことができます。さらに、疼痛管理や身体リハビリテーションにもVRが採用されており、患者が痛みを紛らわせたり動きを促したりするインタラクティブなエクササイズに取り組むことで、回復を促進することができます。この技術により、治療者はリアルタイムのデータを通じて患者の経過をモニターし、それに応じて治療計画を調整することができます。VR療法は遠隔治療の選択肢を促進し、遠隔地や十分なサービスを受けていない地域の人々も治療介入にアクセスできるようにすることで、メンタルヘルス・サービスの範囲を拡大することができます。

市場促進要因

患者エンゲージメントと没入感の向上

デジタル治療薬の受け入れ拡大

費用対効果とリソースの最適化

主な市場課題

導入コストの高さ

既存の治療フレームワークへの統合

主な市場動向

曝露療法へのVR導入の増加

VRと認知行動療法（CBT）の統合

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界の治療におけるバーチャルリアリティ市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 技術別（フルイマーシブVR、セミイマーシブVR、非イマーシブVR）
  • デバイス別（ヘッドマウント、ジェスチャーコントロール、プロジェクター）
  • 用途別（恐怖症治療、ロボット手術、視覚化、リハビリテーション、心的外傷後ストレス障害の治療、自閉症の治療、手術シミュレーション）
  • 地域別
  • 企業別（2023）
• 市場マップ

第6章 北米の治療におけるバーチャルリアリティ市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 技術別
  • デバイス別
  • 用途別
  • 国別
• 北米：国別分析
  • 米国
  • カナダ
  • メキシコ

第7章 欧州の治療におけるバーチャルリアリティ市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 技術別
  • デバイス別
  • 用途別
  • 国別
• 欧州：国別分析
  • ドイツ
  • 英国
  • イタリア
  • フランス
  • スペイン

第8章 アジア太平洋地域の治療におけるバーチャルリアリティ市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 技術別
  • デバイス別
  • 用途別
  • 国別
• アジア太平洋地域：国別分析
  • 中国
  • インド
  • 日本
  • 韓国
  • オーストラリア

第9章 南米の治療におけるバーチャルリアリティ市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 技術別
  • デバイス別
  • 用途別
  • 国別
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカの治療におけるバーチャルリアリティ市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 技術別
  • デバイス別
  • 用途別
  • 国別
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート
  • トルコ

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

第13章 企業プロファイル

• Siemens AG
• Virtalis Holding Limited（Virtalis Group）
• Vuzix Corporation
• Elevate Healthcare, Inc.
• Qualcomm Incorporated
• Virtual Realities, LLC
• Brainlab AG
• Surgical Science Sweden AB

第14章 戦略的提言

第15章 調査会社について・免責事項

Global Virtual Reality in Therapy Market was valued at USD 2.31 billion in 2023 and is expected to reach USD 4.91 billion by 2029 with a CAGR of 13.24% during the forecast period. The Virtual Reality (VR) in therapy market refers to the integration of immersive virtual reality technology into therapeutic practices to treat various psychological and physical conditions. This innovative approach utilizes VR simulations to create controlled environments that can help patients confront fears, practice social skills, or experience scenarios for rehabilitation purposes. VR therapy encompasses a wide range of applications, including exposure therapy for anxiety disorders, phobias, and post-traumatic stress disorder (PTSD), where patients can gradually face their fears in a safe, controlled setting. In addition, VR is employed in pain management and physical rehabilitation, enabling patients to engage in interactive exercises that distract from pain and encourage movement, thus enhancing recovery. The technology allows therapists to monitor patient progress through real-time data and adjust treatment plans, accordingly, ensuring personalized care tailored to individual needs. VR therapy can facilitate remote treatment options, making therapeutic interventions accessible to individuals in remote or underserved areas, thereby expanding the reach of mental health services.

Key Market Drivers

Enhanced Patient Engagement and Immersion

One of the primary drivers of the Global Virtual Reality (VR) therapy market is its ability to enhance patient engagement and immersion during treatment sessions. Traditional therapy methods often struggle to maintain patient interest and motivation, particularly in long-term treatments. VR addresses this challenge by offering a highly interactive and immersive environment that captivates patients' attention. By simulating real-life scenarios, VR allows patients to confront and manage their fears or anxieties in a controlled setting, significantly improving therapeutic outcomes. For instance, individuals suffering from phobias can experience gradual exposure to their triggers in a safe and manageable way, enabling them to develop coping strategies more effectively. Additionally, VR therapy can create engaging experiences for patients with cognitive or developmental disorders, making therapy sessions more enjoyable and beneficial. This immersive nature of VR not only fosters a deeper connection between patients and their therapeutic processes but also encourages adherence to treatment plans. As mental health awareness rises and the demand for innovative therapeutic solutions grows, the integration of VR technology into therapeutic practices is expected to expand, further driving market growth.

Increasing Acceptance of Digital Therapeutics

The increasing acceptance of digital therapeutics is another significant driver for the Global VR therapy market. With the proliferation of digital health technologies and a growing emphasis on personalized medicine, healthcare providers and patients alike are recognizing the benefits of integrating VR into therapeutic approaches. Regulatory bodies are becoming more supportive of digital health solutions, leading to greater legitimacy and acceptance of VR as a viable therapeutic tool. As evidence of the effectiveness of VR in treating various conditions, such as PTSD, anxiety disorders, and chronic pain, accumulates, healthcare providers are more inclined to incorporate it into their treatment modalities. Furthermore, the ongoing advancements in VR technology, including improvements in hardware and software, enhance the efficacy and usability of these solutions, making them more attractive to practitioners and patients. The rise of telehealth services has also facilitated the integration of VR therapy into remote treatment settings, allowing practitioners to reach a broader audience. This growing trend toward digital therapeutics reflects a shift in patient expectations, with an increasing demand for innovative and accessible treatment options. As a result, the VR therapy market is poised to benefit significantly from this acceptance, leading to expanded adoption across various healthcare sectors.

Cost-Effectiveness and Resource Optimization

Cost-effectiveness and resource optimization represent critical drivers for the Global VR therapy market's growth. As healthcare systems globally face mounting pressures to deliver effective treatments while managing costs, VR therapy offers a solution that can reduce expenditures associated with traditional therapy methods. VR can streamline treatment processes by enabling multiple patients to engage with therapeutic content simultaneously, thus maximizing resource utilization. Additionally, VR can decrease the need for extensive in-person sessions, minimizing travel and facility costs for both providers and patients. This is particularly advantageous for patients living in remote or underserved areas, as VR therapy can be delivered through telehealth platforms, expanding access to care. Furthermore, the ability of VR to provide effective treatment for various mental health conditions means that healthcare systems can potentially reduce long-term costs associated with untreated mental health issues, such as hospitalizations and medication management. By demonstrating its effectiveness in diverse therapeutic applications, VR therapy is increasingly viewed as a cost-effective alternative, encouraging healthcare providers to invest in this technology. As cost pressures continue to shape the healthcare landscape, the VR therapy market is expected to thrive, driven by its ability to deliver high-quality care while optimizing resources.

Key Market Challenges

High Cost of Implementation

One of the primary challenges facing the Global Virtual Reality (VR) therapy market is the high cost associated with the implementation and maintenance of VR systems. The initial investment required for advanced VR hardware and software can be prohibitive, particularly for smaller clinics and healthcare providers. High-quality VR headsets, such as the Oculus Quest or HTC Vive, often carry steep price tags, and additional expenses may include powerful computing systems to run the software effectively. Moreover, creating bespoke VR content tailored to specific therapeutic needs can incur substantial development costs. For healthcare facilities with limited budgets, the financial burden of adopting VR therapy solutions can deter investment in this promising technology, hindering its widespread adoption. This challenge is further exacerbated by the need for ongoing technical support and updates to maintain system performance and relevance, adding to the total cost of ownership. The economic constraints can lead to a disparity in access to VR therapy, where larger, more financially robust institutions can leverage advanced technologies while smaller practices struggle to keep pace. Consequently, this situation can create a significant barrier to entry, limiting the potential market size and slowing the growth of VR therapy as a viable treatment option. To address this challenge, stakeholders in the VR therapy market must explore alternative financing models, such as leasing arrangements or collaborative partnerships, to alleviate upfront costs. Additionally, demonstrating the long-term cost savings and efficiency gains from VR therapy, such as reduced patient treatment times and improved outcomes, may help justify initial investments to skeptical healthcare providers. Establishing standardized protocols and cost-effective content creation solutions could also help democratize access to VR therapy, making it more attainable for a wider range of healthcare professionals and patients.

Integration into Existing Therapeutic Frameworks

Another significant challenge facing the Global VR therapy market is the integration of VR technology into existing therapeutic frameworks. Many healthcare providers are accustomed to traditional therapeutic methods, and the transition to VR-based treatments requires not only changes in technology but also shifts in practice and mindset. Healthcare professionals may be resistant to adopting new methodologies, particularly if they are unsure about the efficacy of VR therapy compared to established practices. This skepticism can be rooted in a lack of understanding of the technology and its applications, as well as concerns about patient safety and the potential for adverse effects. Additionally, integrating VR into therapeutic protocols necessitates comprehensive training for clinicians to ensure they can effectively implement and supervise VR sessions. This training can be resource-intensive and time-consuming, adding to the operational burden of healthcare facilities. Furthermore, healthcare systems often have rigid structures and established workflows, making it difficult to incorporate new technologies without significant disruptions. The challenge is compounded by the need for interdisciplinary collaboration, as successful VR therapy often requires input from psychologists, psychiatrists, occupational therapists, and technology experts. Ensuring that all stakeholders are aligned and working towards a common goal can be a daunting task, especially in larger organizations with established hierarchies and departmental silos. To overcome this challenge, the VR therapy market must focus on building strong evidence of the technology's efficacy through rigorous clinical trials and case studies that highlight positive patient outcomes. Developing training programs that emphasize the integration of VR into existing treatment modalities and fostering a culture of innovation within healthcare organizations can facilitate smoother transitions. Additionally, creating user-friendly platforms that seamlessly blend VR therapy with traditional approaches can help ease the integration process, making it more attractive to healthcare providers.

Key Market Trends

Increased Adoption of VR for Exposure Therapy

The adoption of Global virtual reality (VR) in therapy, particularly for exposure therapy, is a significant trend that is reshaping the therapeutic landscape. Exposure therapy, traditionally employed to treat anxiety disorders, phobias, and post-traumatic stress disorder (PTSD), aims to gradually expose patients to the source of their fears in a controlled environment. VR enhances this process by creating immersive simulations that allow patients to confront their fears safely. As research continues to validate the efficacy of VR exposure therapy, mental health professionals are increasingly integrating this technology into their practice. The ability to tailor VR experiences to individual patient needs facilitates more personalized treatment plans, promoting better engagement and outcomes. Additionally, the COVID-19 pandemic has accelerated the shift toward remote therapy, making VR an attractive option for providing therapy in a virtual setting. By reducing geographical barriers, VR expands access to therapeutic resources, allowing patients in remote areas to benefit from advanced therapeutic techniques. The growing number of VR therapy platforms and applications, coupled with advancements in VR technology, is expected to drive market growth. As therapists gain more familiarity and training with VR tools, the acceptance of VR as a legitimate therapeutic modality will likely increase, fostering a greater shift in the mental health treatment paradigm.

Integration of VR with Cognitive Behavioral Therapy (CBT)

Another notable trend in the Global Virtual Reality in Therapy market is the integration of VR with Cognitive Behavioral Therapy (CBT). CBT is a widely recognized and effective treatment for various mental health conditions, including depression, anxiety, and obsessive-compulsive disorder (OCD). The incorporation of VR into CBT practices offers a unique opportunity to enhance traditional therapeutic techniques. By creating controlled virtual environments, therapists can simulate real-life scenarios that trigger anxiety or distress in patients, allowing them to practice coping strategies in a safe space. This innovative approach enables therapists to monitor patients' reactions in real time and provide immediate feedback, improving the overall therapeutic experience. Furthermore, VR technology facilitates the gradual exposure of patients to their fears, which is a critical component of CBT. The flexibility of VR applications allows for the customization of scenarios, ensuring that each patient receives a tailored therapeutic experience that meets their specific needs. As awareness of the benefits of combining VR with CBT grows, more mental health practitioners are likely to adopt this integrated approach, leading to improved treatment outcomes and increased patient satisfaction. The continuous development of VR platforms and tools specifically designed for CBT will further enhance this trend, promoting the expansion of VR therapy into mainstream mental health care.

Segmental Insights

Technology Insights

The Full Immersive VR segment held the largest Market share in 2023. The Full Immersive Virtual Reality (VR) market in therapy is experiencing robust growth driven by several key factors that underscore its transformative potential in mental health and rehabilitation practices. One of the primary drivers is the increasing recognition of the efficacy of VR in treating various psychological conditions, including anxiety disorders, post-traumatic stress disorder (PTSD), phobias, and depression. Full immersive VR provides a safe, controlled environment where patients can confront and manage their fears or traumatic experiences under the guidance of a trained therapist. This therapeutic approach facilitates exposure therapy, enabling patients to engage with virtual simulations that replicate real-world scenarios, thereby enhancing the effectiveness of their treatment. The rising prevalence of mental health issues globally has prompted healthcare providers to seek innovative solutions that can reach more patients and provide tailored interventions. Full immersive VR offers a unique advantage in this regard, as it can be utilized in diverse settings, including hospitals, outpatient clinics, and even at home, making therapy more accessible to those in need. Another significant driver is the ongoing advancements in VR technology, which have led to the development of more sophisticated, user-friendly, and affordable systems. The improved visual fidelity and interactivity of full immersive VR experiences enhance user engagement and facilitate deeper therapeutic outcomes.

The integration of biometric feedback mechanisms, such as heart rate monitors and motion tracking, allows therapists to monitor patient responses in real-time, adapting sessions to maximize therapeutic efficacy. The growing body of research supporting the effectiveness of full immersive VR in therapy is also a critical factor driving its adoption. Numerous studies have demonstrated positive outcomes, with patients showing significant improvements in symptoms and overall well-being. This increasing evidence base has encouraged mental health professionals to incorporate VR into their treatment protocols, further solidifying its role in modern therapeutic practices. Additionally, as mental health awareness rises and stigma diminishes, more individuals are seeking help and exploring diverse treatment options, including VR therapy. The COVID-19 pandemic has accelerated the shift toward telehealth and remote therapy solutions, creating a conducive environment for the adoption of full immersive VR in therapy. With restrictions on in-person interactions, VR offers an innovative way to deliver therapeutic interventions while maintaining safety and social distancing. This trend has prompted healthcare providers to invest in VR technology as part of their telehealth offerings, further driving market growth. Moreover, collaborations between technology companies, mental health professionals, and academic institutions are fostering the development of specialized VR applications tailored for various therapeutic modalities. These partnerships are essential for creating effective content that meets the specific needs of different patient populations, enhancing the overall therapeutic experience. The continuous evolution of VR software, along with the introduction of gamified elements and engaging narratives, is also enhancing patient motivation and adherence to treatment protocols. In conclusion, the Full Immersive VR market in therapy is driven by the increasing acceptance of VR as a valid therapeutic tool, advancements in technology, growing research backing its efficacy, heightened mental health awareness, and the impact of the COVID-19 pandemic on treatment delivery methods. As these trends continue to evolve, the market is expected to expand, offering significant opportunities for innovation and improved patient outcomes in therapeutic settings.

Regional Insights

North America region held the largest market share in 2023. The Virtual Reality (VR) therapy market in North America is experiencing robust growth, driven by several key factors that highlight the increasing acceptance and integration of VR technologies in therapeutic practices. One of the primary drivers is the rising prevalence of mental health disorders, including anxiety, depression, and post-traumatic stress disorder (PTSD). Traditional therapeutic methods often face challenges such as accessibility and patient engagement, making VR an attractive alternative. VR therapy provides immersive environments that allow patients to confront their fears, practice mindfulness, and engage in cognitive behavioral therapy (CBT) in a controlled setting, thus enhancing treatment effectiveness.

The COVID-19 pandemic has accelerated the adoption of telehealth solutions, including VR therapy, as healthcare providers and patients seek safe, remote treatment options. This shift has led to increased investment in VR technologies by mental health professionals, creating a growing ecosystem of applications designed to address various psychological conditions. Furthermore, advancements in VR hardware and software are making these technologies more user-friendly and cost-effective, allowing therapists to integrate them seamlessly into their practice. The North American region benefits from a well-established healthcare infrastructure and significant funding for mental health initiatives, which facilitates the integration of innovative therapies like VR. Collaborations between technology companies and healthcare providers are further enhancing the development of VR applications tailored for therapeutic use, ensuring that they meet clinical standards and address specific patient needs. Moreover, increasing awareness of mental health issues and the effectiveness of VR therapy in treating conditions such as phobias, autism spectrum disorders, and chronic pain management is encouraging healthcare providers to adopt these solutions.

Regulatory bodies are also beginning to recognize the potential of VR therapy, leading to a more favorable environment for its implementation in clinical settings. The potential for VR therapy to provide personalized treatment experiences, combined with its ability to track patient progress through data analytics, is attracting both practitioners and patients. As patients increasingly seek innovative and effective treatment options, the demand for VR therapy is expected to rise. Additionally, educational institutions and training programs are incorporating VR simulations into their curricula, preparing the next generation of therapists to utilize these technologies effectively in their practices. The increasing prevalence of smartphone usage and the availability of VR-compatible devices are also contributing to the market's growth, as they make VR therapy more accessible to a broader audience. With the convergence of these factors, the North American VR therapy market is poised for continued expansion, as both healthcare providers and patients recognize the value of integrating immersive technologies into therapeutic practices. The ongoing research and clinical trials validating the efficacy of VR therapy further bolster its adoption, creating a positive feedback loop that drives innovation and investment in this burgeoning field. As the market matures, the potential for VR therapy to revolutionize mental health treatment in North America becomes increasingly apparent, presenting significant opportunities for stakeholders across the healthcare and technology sectors.

Key Market Players

• Siemens AG
• Virtalis Holding Limited (Virtalis Group)
• Vuzix Corporation
• Elevate Healthcare, Inc.
• Qualcomm Incorporated
• Virtual Realities, LLC
• Brainlab AG
• Surgical Science Sweden AB

Report Scope:

In this report, the Global Virtual Reality in Therapy Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Virtual Reality in Therapy Market, By Technology:

• Full Immersive VR
• Semi-Immersive VR
• Non- Immersive VR

Virtual Reality in Therapy Market, By Device:

• Head Mount
• Gesture Control
• Projectors

Virtual Reality in Therapy Market, By Application:

• Phobia Treatment
• Robotic Surgery
• Visualization
• Rehabilitation
• Treatment of Post-Traumatic Stress Disorder
• Treatment of Autism
• Surgery Simulation

Virtual Reality in Therapy Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait
  • Turkey

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Virtual Reality in Therapy Market.

Available Customizations:

Global Virtual Reality in Therapy Market report with the given Market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional Market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
• 1.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Formulation of the Scope
• 2.4. Assumptions and Limitations
• 2.5. Sources of Research
  • 2.5.1. Secondary Research
  • 2.5.2. Primary Research
• 2.6. Approach for the Market Study
  • 2.6.1. The Bottom-Up Approach
  • 2.6.2. The Top-Down Approach
• 2.7. Methodology Followed for Calculation of Market Size & Market Shares
• 2.8. Forecasting Methodology
  • 2.8.1. Data Triangulation & Validation

3. Executive Summary

4. Voice of Customer

5. Global Virtual Reality in Therapy Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Technology (Full Immersive VR, Semi-Immersive VR, and Non- Immersive VR)
  • 5.2.2. By Device (Head Mount, Gesture Control, And Projectors)
  • 5.2.3. By Application (Phobia Treatment, Robotic Surgery, Visualization, Rehabilitation, Treatment of Post-Traumatic Stress Disorder, Treatment of Autism, and Surgery Simulation)
  • 5.2.4. By Region
  • 5.2.5. By Company (2023)
• 5.3. Market Map

6. North America Virtual Reality in Therapy Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Technology
  • 6.2.2. By Device
  • 6.2.3. By Application
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Virtual Reality in Therapy Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Technology
      • 6.3.1.2.2. By Device
      • 6.3.1.2.3. By Application
  • 6.3.2. Canada Virtual Reality in Therapy Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Technology
      • 6.3.2.2.2. By Device
      • 6.3.2.2.3. By Application
  • 6.3.3. Mexico Virtual Reality in Therapy Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Technology
      • 6.3.3.2.2. By Device
      • 6.3.3.2.3. By Application

7. Europe Virtual Reality in Therapy Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Technology
  • 7.2.2. By Device
  • 7.2.3. By Application
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Virtual Reality in Therapy Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Technology
      • 7.3.1.2.2. By Device
      • 7.3.1.2.3. By Application
  • 7.3.2. United Kingdom Virtual Reality in Therapy Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Technology
      • 7.3.2.2.2. By Device
      • 7.3.2.2.3. By Application
  • 7.3.3. Italy Virtual Reality in Therapy Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Technology
      • 7.3.3.2.2. By Device
      • 7.3.3.2.3. By Application
  • 7.3.4. France Virtual Reality in Therapy Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Technology
      • 7.3.4.2.2. By Device
      • 7.3.4.2.3. By Application
  • 7.3.5. Spain Virtual Reality in Therapy Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Technology
      • 7.3.5.2.2. By Device
      • 7.3.5.2.3. By Application

8. Asia-Pacific Virtual Reality in Therapy Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Technology
  • 8.2.2. By Device
  • 8.2.3. By Application
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Virtual Reality in Therapy Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Technology
      • 8.3.1.2.2. By Device
      • 8.3.1.2.3. By Application
  • 8.3.2. India Virtual Reality in Therapy Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Technology
      • 8.3.2.2.2. By Device
      • 8.3.2.2.3. By Application
  • 8.3.3. Japan Virtual Reality in Therapy Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Technology
      • 8.3.3.2.2. By Device
      • 8.3.3.2.3. By Application
  • 8.3.4. South Korea Virtual Reality in Therapy Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Technology
      • 8.3.4.2.2. By Device
      • 8.3.4.2.3. By Application
  • 8.3.5. Australia Virtual Reality in Therapy Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Technology
      • 8.3.5.2.2. By Device
      • 8.3.5.2.3. By Application

9. South America Virtual Reality in Therapy Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Technology
  • 9.2.2. By Device
  • 9.2.3. By Application
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Virtual Reality in Therapy Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Technology
      • 9.3.1.2.2. By Device
      • 9.3.1.2.3. By Application
  • 9.3.2. Argentina Virtual Reality in Therapy Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Technology
      • 9.3.2.2.2. By Device
      • 9.3.2.2.3. By Application
  • 9.3.3. Colombia Virtual Reality in Therapy Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Technology
      • 9.3.3.2.2. By Device
      • 9.3.3.2.3. By Application

10. Middle East and Africa Virtual Reality in Therapy Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Technology
  • 10.2.2. By Device
  • 10.2.3. By Application
  • 10.2.4. By Country
• 10.3. Middle East and Africa: Country Analysis
  • 10.3.1. South Africa Virtual Reality in Therapy Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Technology
      • 10.3.1.2.2. By Device
      • 10.3.1.2.3. By Application
  • 10.3.2. Saudi Arabia Virtual Reality in Therapy Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Technology
      • 10.3.2.2.2. By Device
      • 10.3.2.2.3. By Application
  • 10.3.3. UAE Virtual Reality in Therapy Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Technology
      • 10.3.3.2.2. By Device
      • 10.3.3.2.3. By Application
  • 10.3.4. Kuwait Virtual Reality in Therapy Market Outlook
    • 10.3.4.1. Market Size & Forecast
      • 10.3.4.1.1. By Value
    • 10.3.4.2. Market Share & Forecast
      • 10.3.4.2.1. By Technology
      • 10.3.4.2.2. By Device
      • 10.3.4.2.3. By Application
  • 10.3.5. Turkey Virtual Reality in Therapy Market Outlook
    • 10.3.5.1. Market Size & Forecast
      • 10.3.5.1.1. By Value
    • 10.3.5.2. Market Share & Forecast
      • 10.3.5.2.1. By Technology
      • 10.3.5.2.2. By Device
      • 10.3.5.2.3. By Application

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

13. Company Profiles

• 13.1. Siemens AG
  • 13.1.1. Business Overview
  • 13.1.2. Key Revenue and Financials
  • 13.1.3. Recent Developments
  • 13.1.4. Key Personnel/Key Contact Person
  • 13.1.5. Key Product/Services Offered
• 13.2. Virtalis Holding Limited (Virtalis Group)
  • 13.2.1. Business Overview
  • 13.2.2. Key Revenue and Financials
  • 13.2.3. Recent Developments
  • 13.2.4. Key Personnel/Key Contact Person
  • 13.2.5. Key Product/Services Offered
• 13.3. Vuzix Corporation
  • 13.3.1. Business Overview
  • 13.3.2. Key Revenue and Financials
  • 13.3.3. Recent Developments
  • 13.3.4. Key Personnel/Key Contact Person
  • 13.3.5. Key Product/Services Offered
• 13.4. Elevate Healthcare, Inc.
  • 13.4.1. Business Overview
  • 13.4.2. Key Revenue and Financials
  • 13.4.3. Recent Developments
  • 13.4.4. Key Personnel/Key Contact Person
  • 13.4.5. Key Product/Services Offered
• 13.5. Qualcomm Incorporated
  • 13.5.1. Business Overview
  • 13.5.2. Key Revenue and Financials
  • 13.5.3. Recent Developments
  • 13.5.4. Key Personnel/Key Contact Person
  • 13.5.5. Key Product/Services Offered
• 13.6. Virtual Realities, LLC
  • 13.6.1. Business Overview
  • 13.6.2. Key Revenue and Financials
  • 13.6.3. Recent Developments
  • 13.6.4. Key Personnel/Key Contact Person
  • 13.6.5. Key Product/Services Offered
• 13.7. Brainlab AG
  • 13.7.1. Business Overview
  • 13.7.2. Key Revenue and Financials
  • 13.7.3. Recent Developments
  • 13.7.4. Key Personnel/Key Contact Person
  • 13.7.5. Key Product/Services Offered
• 13.8. Surgical Science Sweden AB
  • 13.8.1. Business Overview
  • 13.8.2. Key Revenue and Financials
  • 13.8.3. Recent Developments
  • 13.8.4. Key Personnel/Key Contact Person
  • 13.8.5. Key Product/Services Offered

14. Strategic Recommendations

15. About Us & Disclaimer